Clinical and laboratory characteristics of clozapine treated schizophrenia patients referred to a national immunodeficiency clinic reveals a B-cell signature resembling CVID

M.J. Ponsford; R. Steven; K. Bramhall; M Burgess; S Wijetilleka; E. Carne; F McGuire; C. Price; M. Moody; S Zouwail; T Tahir; D. Farewell; T. El-Shanawany; S. Jolles

doi:10.1101/19007815

Article Information

doi

https://doi.org/10.1101/19007815

History

October 2, 2019.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

M.J. Ponsford1,5,*,
R. Steven1,
K. Bramhall1,
M Burgess1,
S Wijetilleka1,
E. Carne1,
F McGuire1,
C. Price1,
M. Moody1,
S Zouwail2,
T Tahir3,
D. Farewell4,
T. El-Shanawany1 and
S. Jolles1

¹Immunodeficiency Centre for Wales, University Hospital Wales, Cardiff, United Kingdom
²Department of Medical Biochemistry & Immunology, University Hospital Wales, Cardiff, United Kingdom and Department of Medical Biochemistry, Medical School, Alexandria University, Egypt
³University Hospital Wales, Liaison Psychiatry, Cardiff, United Kingdom
⁴Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom
⁵School of Medicine, Cardiff University

↵*Corresponding Author Email ponsfordm{at}cardiff.ac.uk

Author Contributions MP and SJ conceived study, and performed data extraction and analysis, and wrote the first draft. RS, KB, and MB performed immunophenotyping and assisted in data extraction.